Company research / ZURA
Zura Bio Ltd (ZURA)
- Sector Manufacturing
- Fiscal year ends Dec 31
Key ratios (year ended 2025-12-31)
-67.6%
Return on year-end equity
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.
Annual financials
| Period ended | TTM to 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| R&D Expense | $58.36M | $42.08M | $24.40M | $44.00M | n/a | n/a |
| Operating Income | -$92.75M | -$75.25M | -$55.19M | -$62.64M | -$2.68M | n/a |
| Depreciation & Amortization | n/a | $49.0K | $9.0K | n/a | n/a | n/a |
| EBITDA | n/a | -$75.20M | -$55.18M | n/a | n/a | n/a |
| Net Income | -$85.74M | -$68.65M | -$52.40M | -$60.36M | -$25.70M | n/a |
| EPS (Diluted) | n/a | -$1.06 | -$0.60 | -$2.09 | n/a | n/a |
| Total Assets | $213.40M | $113.95M | $179.53M | $100.84M | $5.26M | $140.55M |
| Total Liabilities | $16.32M | $12.41M | $19.51M | $21.29M | $14.82M | $10.35M |
| Shareholders' Equity | n/a | $101.54M | $146.81M | $59.33M | -$32.06M | -$9.18M |
| Cash & Equivalents | $205.13M | $109.41M | $176.50M | $99.81M | $13.8K | $729.2K |
| Operating Cash Flow | n/a | -$64.81M | -$28.08M | -$15.05M | -$1.07M | n/a |
| Capital Expenditures | n/a | $113.0K | $75.0K | n/a | n/a | n/a |
| Free Cash Flow | n/a | -$64.93M | -$28.15M | n/a | n/a | n/a |
| Shares Outstanding | 95.42M | 73.68M | 65.30M | 43.59M | 279.7K | n/a |
| Weighted Average Diluted Shares | n/a | 94.16M | 75.07M | 33.06M | n/a | n/a |
| EPS (Basic) | n/a | -$1.06 | -$0.60 | -$2.09 | n/a | n/a |